Urinary tract infection. Urinary tract infection, site not specified
Conditions
Interventions
Intervention 1: Intervention group: In addition to receiving standard treatment (antibiotic suitable for symptoms, age and gender), children will receive mercury-free Omega-3 capsules produced by Zahr
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to 18 Years
Inclusion criteria
Inclusion criteria: Children 4-18 years old with urinary tract infection Consent to participate in the study
Exclusion criteria
Exclusion criteria: The presence of underlying kidney and liver disease Sensitivity to omega-3
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fever. Timepoint: The beginning and end of treatment. Method of measurement: Mercury Therommeter.;Dysuria. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Frequency. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Abdominal pain. Timepoint: The beginning and end of treatment. Method of measurement: Take a history.;Urinary incontinence. Timepoint: The beginning and end of treatment. Method of measurement: Take a history. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Manijeh Kahbazi
Arak University of Medical Sciences
Outcome results
None listed